Literature DB >> 20013136

Molecular docking and 3D-QSAR studies on triazolinone and pyridazinone, non-nucleoside inhibitor of HIV-1 reverse transcriptase.

Sree Kanth Sivan1, Vijjulatha Manga.   

Abstract

Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are allosteric inhibitors of the HIV-1 reverse transcriptase. Recently a series of Triazolinone and Pyridazinone were reported as potent inhibitors of HIV-1 wild type reverse transcriptase. In the present study, docking and 3D quantitative structure activity relationship (3D QSAR) studies involving comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) were performed on 31 molecules. Ligands were built and minimized using Tripos force field and applying Gasteiger-Hückel charges. These ligands were docked into protein active site using GLIDE 4.0. The docked poses were analyzed; the best docked poses were selected and aligned. CoMFA and CoMSIA fields were calculated using SYBYL6.9. The molecules were divided into training set and test set, a PLS analysis was performed and QSAR models were generated. The model showed good statistical reliability which is evident from the r2 nv, q2 loo and r2 pred values. The CoMFA model provides the most significant correlation of steric and electrostatic fields with biological activities. The CoMSIA model provides a correlation of steric, electrostatic, acceptor and hydrophobic fields with biological activities. The information rendered by 3D QSAR model initiated us to optimize the lead and design new potential inhibitors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20013136     DOI: 10.1007/s00894-009-0625-8

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  9 in total

1.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

2.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

Authors:  R D Cramer; D E Patterson; J D Bunce
Journal:  J Am Chem Soc       Date:  1988-08-01       Impact factor: 15.419

Review 3.  HIV reverse transcriptase structures: designing new inhibitors and understanding mechanisms of drug resistance.

Authors:  Jingshan Ren; David K Stammers
Journal:  Trends Pharmacol Sci       Date:  2005-01       Impact factor: 14.819

4.  Probing nonnucleoside inhibitor-induced active-site distortion in HIV-1 reverse transcriptase by transient kinetic analyses.

Authors:  Qing Xia; Jessica Radzio; Karen S Anderson; Nicolas Sluis-Cremer
Journal:  Protein Sci       Date:  2007-08       Impact factor: 6.725

5.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

Review 6.  HIV-1 RT nonnucleoside inhibitors and their interaction with RT for antiviral drug development.

Authors:  Zhigang Zhou; Xin Lin; Jeffry D Madura
Journal:  Infect Disord Drug Targets       Date:  2006-12

7.  Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase.

Authors:  Zachary K Sweeney; Sahaja Acharya; Andrew Briggs; James P Dunn; Todd R Elworthy; Jennifer Fretland; Anthony M Giannetti; Gabrielle Heilek; Yu Li; Ann C Kaiser; Michael Martin; Y David Saito; Mark Smith; Judy M Suh; Steven Swallow; Jeffrey Wu; Julie Q Hang; Amy S Zhou; Klaus Klumpp
Journal:  Bioorg Med Chem Lett       Date:  2008-06-28       Impact factor: 2.823

8.  Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptase.

Authors:  Zachary K Sweeney; James P Dunn; Yu Li; Gabrielle Heilek; Pete Dunten; Todd R Elworthy; Xiaochun Han; Seth F Harris; Donald R Hirschfeld; J Heather Hogg; Walter Huber; Ann C Kaiser; Denis J Kertesz; Woongki Kim; Taraneh Mirzadegan; Michael G Roepel; Y David Saito; Tania M P C Silva; Steven Swallow; Jahari L Tracy; Armando Villasenor; Harit Vora; Amy S Zhou; Klaus Klumpp
Journal:  Bioorg Med Chem Lett       Date:  2008-06-28       Impact factor: 2.823

9.  Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptase.

Authors:  Zachary K Sweeney; Seth F Harris; Seth F Arora; Hassan Javanbakht; Yu Li; Jennifer Fretland; James P Davidson; J Roland Billedeau; Shelley K Gleason; Donald Hirschfeld; Joshua J Kennedy-Smith; Taraneh Mirzadegan; Ralf Roetz; Mark Smith; Sarah Sperry; Judy M Suh; Jeffrey Wu; Stan Tsing; Armando G Villaseñor; Amber Paul; Guoping Su; Gabrielle Heilek; Julie Q Hang; Amy S Zhou; Jesper A Jernelius; Fang-Jie Zhang; Klaus Klumpp
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

  9 in total
  8 in total

1.  3D-QSAR and molecular docking studies of azaindole derivatives as Aurora B kinase inhibitors.

Authors:  Ping Lan; Wan-Na Chen; Ping-Hua Sun; Wei-Min Chen
Journal:  J Mol Model       Date:  2010-08-11       Impact factor: 1.810

2.  CoMFA and CoMSIA studies of 1,2-dihydropyridine derivatives as anticancer agents.

Authors:  Ismail Salama; Mohamed A O Abdel-Fattah; Marwa S Hany; Shaimaa A El-Sharif; Mahmoud A M El-Naggar; Rasha M H Rashied; Gary A Piazza; Ashraf H Abadi
Journal:  Med Chem       Date:  2012-05       Impact factor: 2.745

3.  Structural determinants of imidacloprid-based nicotinic acetylcholine receptor inhibitors identified using 3D-QSAR, docking and molecular dynamics.

Authors:  Qinfan Li; Xiangya Kong; Zhengtao Xiao; Lihui Zhang; Fangfang Wang; Hong Zhang; Yan Li; Yonghua Wang
Journal:  J Mol Model       Date:  2011-11-26       Impact factor: 1.810

4.  3D-QSAR and molecular docking studies on fused pyrazoles as p38α mitogen-activated protein kinase inhibitors.

Authors:  Ping Lan; Zhi-Jian Huang; Jun-Rong Sun; Wei-Min Chen
Journal:  Int J Mol Sci       Date:  2010-09-17       Impact factor: 5.923

5.  Microwave assisted synthesis, antifungal activity, and DFT study of some novel triazolinone derivatives.

Authors:  Na-Bo Sun; Jian-Zhong Jin; Fang-Yue He
Journal:  Biomed Res Int       Date:  2015-03-12       Impact factor: 3.411

6.  Docking Studies of Methylthiomorpholin Phenols (LQM300 Series) with Angiotensin-Converting Enzyme (ACE).

Authors:  Víctor H Vázquez-Valadez; V H Abrego; Pablo A Martínez; Gabriela Torres; Oscar Zúñiga; Daniel Escutia; Rebeca Vilchis; Ana Ma Velázquez; Luisa Martínez; Mónica Ruiz; Brígida Camacho; Rafael López-Castañares; Enrique Angeles
Journal:  Open Med Chem J       Date:  2013-11-23

7.  Insight into the interactions between novel isoquinolin-1,3-dione derivatives and cyclin-dependent kinase 4 combining QSAR and molecular docking.

Authors:  Junxia Zheng; Hao Kong; James M Wilson; Jialiang Guo; Yiqun Chang; Mengjia Yang; Gaokeng Xiao; Pinghua Sun
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

8.  Prediction and evaluation of the lipase inhibitory activities of tea polyphenols with 3D-QSAR models.

Authors:  Yi-Fang Li; Yi-Qun Chang; Jie Deng; Wei-Xi Li; Jie Jian; Jia-Suo Gao; Xin Wan; Hao Gao; Hiroshi Kurihara; Ping-Hua Sun; Rong-Rong He
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.